LncRNA EGFR‑AS1 promotes lung cancer cell proliferation, invasion and metastasis via regulation of miR‑449a/HDAC1

Exp Ther Med. 2024 Dec 3;29(2):27. doi: 10.3892/etm.2024.12777. eCollection 2025 Feb.

Abstract

There is increasing evidence that long non-coding (lnc)RNA EGFR-AS1 is involved in the development of numerous types of cancer, including non-small-cell lung cancer (NSCLC). The Cancer Genome Atlas (TCGA) demonstrates that EGFR-AS1 is highly expressed in NSCLC. Downregulation of EGFR-AS1 in A549 and PC9 NSCLC cells demonstrates inhibition of NSCLC proliferation, invasion and metastasis. The present study demonstrated that lncRNA EGFR-AS1 was essential for the development of NSCLC through its function as a competitive endogenous RNA binding to miR-449a and upregulating histone deacetylase 1. In brief, it identified a novel signaling pathway that mediated the invasion and metastasis of NSCLC and may therefore provide a new treatment target for NSCLC.

Keywords: competing endogenous RNA; histone deacetylase 1; long non-coding RNA EGFR-AS1; microRNA-449a; non-small cell lung cancer.

Grants and funding

Funding: The present study was supported by a grant from Medical Research Project of Xuhui District, Shanghai, China (grant no. SHXH202006) and a grant from Health system peak discipline construction Project of Xuhui District, Shanghai (grant no. SHXHZDXK202312).